ArticleslgStudy

biology

NKG2A

NKG2A is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand NKG2A rather than just read about it. In short: NKG2A also known as CD159a (Cluster of Differentiation 159a) is an inhibitory NK cell receptor that is part of the NKG2 family and encoded by the KLRC1 gene. NKG2A is expressed predominantly by NK cells, but can also be found on a subset of T cells, especially on CD8+ cytotoxic T cells.

Key takeaways

  • NKG2A belongs to biology; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect NKG2A to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of NKG2A from memory before moving on to harder problems.

Reference excerpt

NKG2A also known as CD159a (Cluster of Differentiation 159a) is an inhibitory NK cell receptor that is part of the NKG2 family and encoded by the KLRC1 gene. NKG2A is expressed predominantly by NK cells, but can also be found on a subset of T cells, especially on CD8+ cytotoxic T cells.

Structure and signaling NKG2A forms heterodimers with CD94 via disulfide bonds and assembles into a transmembrane protein type II. NKG2A contains two immunoreceptor tyrosine-based inhibitory motifs (ITIMs) in its cytoplasmic tail. When the CD94/NKG2A receptor binds to its ligands (see below), these ITIMs initiate a signalling cascade of tyrosine phosphatases, which suppresses NK cell activity.

Ligand and function

Health In humans, CD94/NKG2A receptors bind to the non-classical MHC class I molecule HLA-E. For proper binding, specific peptides presented on HLA-E are required. Since the primary function of HLA-E is to present signal peptides derived from classical MHC class I molecules such as HLA-A, HLA-B or HLA-C, NKG2A allows immune cells to indirectly monitor the expression levels of HLA-A/B/C through complexes of HLA-E and signal peptides. Given that HLA-E is broadly expressed throughout the body, the receptor–ligand interactions of the NKG2A–HLA-E/pHLA axis maintains tolerance to self and ensures suppression of autoimmunity.

Virus infection Certain viruses such as Cytomegalovirus attempt to escape from T cell-mediated immune responses by down-regulating HLA class I molecules including HLA-A, HLA-B or HLA-C. In this case, signal peptides from these HLA molecules are no longer available for presentation on HLA-E. This disrupts the interaction between CD94/NKG2A and HLA-E, leading to loss-of-inhibition of NKG2A-expressing NK cells. As a consequence, NKG2A+ NK cells recognize CMV-infected cells through a mechanism termed missing self. To counteract this recognition, CMV contains the glycoprotein UL40, which provides a viral peptide that mimicks the sequence of self peptides from HLA molecules and is presented on HLA-E. As a result, CD94/NKG2A binds to HLA-E/pUL40, NKG2A+ NK cells remain inhibited, and the virus achieves immune escape. Studies on SARS-CoV-2 have shown that the viral Nsp13-Protein contains a peptide that is presented on HLA-E. Presentation of the viral peptide disrupts the binding to NKG2A and thus causes NK cell activation resulting in protective immune responses against infected cells. Moreover, the Omicron BQ.1 variant has acquired a mutation in this HLA-E-restricted peptide, which diminishes its presentation. This could be a clue that SARS-CoV-2 has evolutionarily adapted to NK cell responses.

Cancer In the context of cancer, NKG2A has been identified as important immune checkpoint. HLA-E is highly expressed across multiple cancer types, preventing adequate immune responses by NKG2A-expressing NK cells and cytotoxic T cells. Similar to other checkpoint inhibitors, the blocking anti-NKG2A antibody monalizumab is currently in clinical testing with the goal to revert NKG2A-dependent inhibition and to unleash immune responses against the cancer.

See also CD94/NKG2 KLRC2 NKG2D

References

Worked examples

Example 1 — a first encounter with NKG2A

Start with the simplest possible case. Write down what NKG2A claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to NKG2A before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about NKG2A ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of NKG2A

In research
NKG2A appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses NKG2A in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
NKG2A is common in secondary-school and first-year university syllabi. It links to neighbouring topics Genes on human chromosome 12, Immune receptors, Transmembrane receptors, so understanding it makes those chapters shorter.
In everyday life
Look for NKG2A outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study NKG2A in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what NKG2A means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain NKG2A out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is NKG2A in simple terms?

NKG2A also known as CD159a (Cluster of Differentiation 159a) is an inhibitory NK cell receptor that is part of the NKG2 family and encoded by the KLRC1 gene. NKG2A is expressed predominantly by NK cells, but can also be found on a subset of T cells, especially on CD8+ cytotoxic T cells.

Why does NKG2A matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study NKG2A?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on NKG2A.

Tags

  • Genes on human chromosome 12
  • Immune receptors
  • Transmembrane receptors

Keep exploring